机译:抗凝治疗达比替兰的患者患者患者患者抗凝治疗患者患者进行抗凝治疗患者心房颤动的心脏致氢化程序
Inst Cardiovasc Res Peoples Liberat Army Dept Cardiol Shenyang Liaoning Peoples R China;
Inst Cardiovasc Res Peoples Liberat Army Dept Cardiol Shenyang Liaoning Peoples R China;
Inst Cardiovasc Res Peoples Liberat Army Dept Cardiol Shenyang Liaoning Peoples R China;
Inst Cardiovasc Res Peoples Liberat Army Dept Cardiol Shenyang Liaoning Peoples R China;
Inst Cardiovasc Res Peoples Liberat Army Dept Cardiol Shenyang Liaoning Peoples R China;
Inst Cardiovasc Res Peoples Liberat Army Dept Cardiol Shenyang Liaoning Peoples R China;
Inst Cardiovasc Res Peoples Liberat Army Dept Cardiol Shenyang Liaoning Peoples R China;
Inst Cardiovasc Res Peoples Liberat Army Dept Cardiol Shenyang Liaoning Peoples R China;
Inst Cardiovasc Res Peoples Liberat Army Dept Cardiol Shenyang Liaoning Peoples R China;
机译:抗凝治疗达比替兰的患者患者患者患者抗凝治疗患者患者进行抗凝治疗患者心房颤动的心脏致氢化程序
机译:左心房阑尾血栓形成尽管持续的非维生素K拮抗剂口腔抗凝血剂治疗,心房颤动患者接受电气心致或导管消融:Dabigatran和Rivaroxaban的比较
机译:伴有不同抗凝治疗的房颤导管消融术患者的围手术期卒中和出血并发症是由于香豆素在预防房颤(AF)导管消融术(COMPARE)的患者血栓栓塞中的作用
机译:非侵入性复发定量分析可预测持续电复律患者的房颤复发
机译:在美国引入达比加群后预防心房颤动患者中风后华法林在抗凝临床中的成本效益
机译:左心房阑尾血栓形成尽管持续的非维生素K拮抗剂口腔抗凝血剂治疗心房颤动患者接受电气心致或导管消融:Dabigatran和Rivaroxaban的比较
机译:勘误表:在心房颤动患者中粘附到拟拟电气心源的心房颤动患者